Renovaro Inc (RENB)
1.46
+0.04
(+2.82%)
USD |
NASDAQ |
May 28, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Renovaro Total Liabilities (Quarterly): 43.68M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 43.68M |
December 31, 2023 | 14.42M |
September 30, 2023 | 10.82M |
June 30, 2023 | 11.80M |
March 31, 2023 | 12.60M |
December 31, 2022 | 13.37M |
September 30, 2022 | 12.75M |
June 30, 2022 | 12.01M |
March 31, 2022 | 18.86M |
December 31, 2021 | 17.52M |
September 30, 2021 | 17.09M |
June 30, 2021 | 14.94M |
March 31, 2021 | 11.38M |
December 31, 2020 | 10.94M |
September 30, 2020 | 10.90M |
June 30, 2020 | 11.83M |
March 31, 2020 | 10.29M |
December 31, 2019 | 7.077M |
September 30, 2019 | 8.438M |
June 30, 2019 | 6.777M |
March 31, 2019 | 25.34M |
December 31, 2018 | 25.24M |
September 30, 2018 | 22.21M |
June 30, 2018 | 23.76M |
March 31, 2018 | 0.9061M |
Date | Value |
---|---|
December 31, 2017 | 5.974M |
September 30, 2017 | 0.9514M |
June 30, 2017 | 2.989M |
March 31, 2017 | 1.988M |
December 31, 2016 | 1.715M |
September 30, 2016 | 1.743M |
June 30, 2016 | 1.508M |
March 31, 2016 | 1.044M |
December 31, 2015 | 0.8939M |
September 30, 2015 | 1.014M |
March 31, 2015 | 0.972M |
December 31, 2014 | 1.758M |
September 30, 2014 | 4.933M |
June 30, 2014 | 3.349M |
March 31, 2014 | 3.098M |
December 31, 2013 | 0.0793M |
September 30, 2013 | 0.0838M |
June 30, 2013 | 0.0676M |
March 31, 2013 | 0.0712M |
December 31, 2012 | 0.0549M |
September 30, 2012 | 0.0473M |
June 30, 2012 | 0.0382M |
March 31, 2012 | 0.0272M |
December 31, 2011 | 0.0226M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.777M
Minimum
Jun 2019
43.68M
Maximum
Mar 2024
13.88M
Average
11.92M
Median
Total Liabilities (Quarterly) Benchmarks
DIH Holding US Inc | -- |
AIM ImmunoTech Inc | 11.36M |
Perspective Therapeutics Inc | 48.40M |
Protalix BioTherapeutics Inc | 60.04M |
Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 212.28M |
Shareholders Equity (Quarterly) | 168.60M |